Provectus Biopharma (PVCT) Reports Q1 Loss of $0.04/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Form 8-K PROVECTUS BIOPHARMACEUTI For: May 10
May 10, 2016 6:25 PM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... MoreForm 10-Q PROVECTUS BIOPHARMACEUTI For: Mar 31
May 10, 2016 6:09 PM EDTTable of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... MoreForm POS AM PROVECTUS BIOPHARMACEUTI
May 9, 2016 5:30 PM EDTAs filed with the Securities and Exchange Commission on May 9, 2016
Registration No. 333-208816
UNITED STATES
... More